95 related articles for article (PubMed ID: 3089177)
21. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
Yoshikawa K; Iwasaki T; Amemiya A; Emoto T; Fujii M; Han N; Itou A; Tsujimura T
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
[TBL] [Abstract][Full Text] [Related]
23. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
[TBL] [Abstract][Full Text] [Related]
26. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
Suzuki M; Sekiguchi I; Tamada T; Nishida M
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
[TBL] [Abstract][Full Text] [Related]
27. [UFT therapy of experimental gastric cancer in beagles induced by ENNG].
Kurihara M; Izumi T; Ichiki H; Tasaka K; Orima H; Miyasaka K; Sasaki Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):881-8. PubMed ID: 3105462
[TBL] [Abstract][Full Text] [Related]
28. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
[TBL] [Abstract][Full Text] [Related]
29. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
[TBL] [Abstract][Full Text] [Related]
30. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
31. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
[TBL] [Abstract][Full Text] [Related]
32. [Effects of UFT in advanced renal cell cancer].
Koseki K; Akaza H; Kishi H; Umeda T; Isurugi K; Niijima T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2061-4. PubMed ID: 3931562
[TBL] [Abstract][Full Text] [Related]
33. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Suzuki M; Sekiguchi I; Ohwada M; Tamada T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
[TBL] [Abstract][Full Text] [Related]
34. [Antitumor effect of intermittent oral administration of UFT against human rectal cancer xenografted in nude mice].
Yamada K; Takao S; Ishizawa T; Shimazu H
Gan To Kagaku Ryoho; 1988 Feb; 15(2):291-6. PubMed ID: 3124769
[TBL] [Abstract][Full Text] [Related]
35. [Study on the preoperative adjuvant therapy of cancer--relation between serum and tumor tissue levels of UFT and OK-432 after administration, and skin reactions to Su-polysaccharide (Su-Ps)].
Kumazawa H; Ishikawa M; Rei S; Saito H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3329-35. PubMed ID: 3120645
[TBL] [Abstract][Full Text] [Related]
36. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
[TBL] [Abstract][Full Text] [Related]
37. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacodynamic study on the effectiveness of UFT against cancer of gastro-intestinal (GI) tract].
Seo Y; Matsuoka H; Kakeji Y; Morita M; Ohno S; Matsukuma A; Tomoda H; Furusawa M
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1775-80. PubMed ID: 8379669
[TBL] [Abstract][Full Text] [Related]
39. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
[TBL] [Abstract][Full Text] [Related]
40. [Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
Ohyama K; Koike D; Odake Y; Takiyama Y; Saitoh T; Kagaya T; Takebe T; Ishii K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2168-74. PubMed ID: 6307180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
